Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Combination therapy for 9+ months maintains symptom improvements after stopping alpha-blockers or finasteride.

Tamsulosin works faster, but both drugs have similar effects after 6 months.

Topical finasteride with EGCG or TA improves drug release and dermal uptake, potentially treating hair loss effectively.

Finasteride use linked to increased suicidality in patients under 45.

Finasteride and dutasteride, used for prostate issues and hair loss, can cause side effects like sexual dysfunction and mental issues, which may continue even after stopping the medication, a condition called post-finasteride syndrome, for which there's currently no cure.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Finasteride and minoxidil work best together for hair loss.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

Saw palmetto supplements may modestly improve hair regrowth with few side effects, but more research is needed.

Dutasteride is approved to help manage prostate enlargement.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Finasteride may cause kidney damage.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Genetics can help tailor treatments for male pattern hair loss, improving outcomes like stabilization or modest regrowth.

The CDC reports 23 measles cases in unvaccinated US kids, new treatments for eosinophilic esophagitis and osteopenia are approved, poor sleep may cause migraines, atopic dermatitis could lead to asthma, migraines might increase Crohn's disease risk, cancer may raise heart disease risk, gout is linked to prostate issues, Cabo Verde is malaria-free, social factors and vitamin D affect dementia risk, smoking increases hair loss risk, certain drugs might lower thyroid disease risk in arthritis, noma is a neglected disease, and meal timing could impact heart health.

Certain medications and patient factors increase the risk of Intraoperative Floppy Iris Syndrome during cataract surgery, but with careful planning and technique adjustments, complications can be minimized.

Pill organizers and cutters can help with taking medication regularly but may affect the medication's effectiveness and safety.

Peptides improve skin health and treatments for hair loss and pregnancy-related skin issues are evolving.

Low-level light therapy is FDA-approved for male pattern hair loss, increases hair count and strength, and is considered safe for use.

Saw palmetto extract is generally safe and can effectively treat Lower Urinary Tract Symptoms, but its evaluation is affected by varying quality and a need for long-term studies.

The article concludes that a thorough diagnosis and treatment plan, including medications, non-invasive methods, or surgery, is important for managing hair loss, with a combination of minoxidil and finasteride being particularly effective.

Dutasteride is more effective than Finasteride in reducing prostate size and PSA levels, but both drugs have similar side effects.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Self-management can help improve symptoms of benign prostatic hyperplasia.

Activating TRPV4 in skin cells helps regrow hair in mice, possibly offering a treatment for hair loss.

Finasteride 1 mg may help prevent prostate issues, but more research is needed to confirm its benefits.

More men are using medication for benign prostatic hyperplasia, influenced by marketing and FDA approvals.